ID   LCSBi006-A
AC   CVCL_A8MD
SY   ND34267-LRRK2/PARK8-G2019S-clone 8; ND34267-LRRK2-clone 8; ND34267-clone 8; ND34267-8
DR   BioSamples; SAMEA10585991
DR   hPSCreg; LCSBi006-A
DR   Wikidata; Q108820777
RX   PubMed=34736041;
CC   From: Luxembourg Centre for Systems Biomedicine; Belvaux; Luxembourg.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; 18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=34736041).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EZ01 ! ND34267
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 30-01-24; Version: 5
//
RX   PubMed=34736041; DOI=10.1016/j.scr.2021.102569;
RA   Novak G., Finkbeiner S., Skibinski G., Skupin A.;
RT   "Generation of two human induced pluripotent stem cell lines from
RT   fibroblasts of unrelated Parkinson's patients carrying the G2019S
RT   mutation in the LRRK2 gene (LCSBi005, LCSBi006).";
RL   Stem Cell Res. 57:102569-102569(2021).
//